News - Tekturna

Filter

Current filters:

Tekturna

Popular Filters

EMA recommends new Rxing info on Victrelis and warnings for aliskiren

20-02-2012

The European Medicines Agency has recommended updating the prescribing information for US drug giant…

Aliskiren TabletsAnti-viralsCardio-vascularEuropeMerck & CoNovartisPharmaceuticalRasilezRegulationTekturnaVictrelis

Novartis cuts jobs, takes $1.22 billion charges

13-01-2012

In anticipation of the blockbuster antihypertensive Diovan’s (valsartan) patent expiration and an…

DiovanFinancialManagementNovartisPatentsPharmaceuticalRasilezTekturna

EMA reviewing Novartis aliskiren-containing drugs

23-12-2011

The European Medicines Agency is reviewing aliskiren-containing medicines, approved for the treatment…

Aliskiren TabletsCardio-vascularEuropeNovartisPharmaceuticalRasilezRegulationTekturna

Novartis to drop Rasilez/Tekturna in high-risk patients with diabetes and renal impairment

21-12-2011

In a major disappointment for Swiss drug major Novartis (NOVN: VX), the company says that, following…

Cardio-vascularDiabetesMarkets & MarketingNovartisPharmaceuticalRasilezResearchTekturna

Back to top